These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 38223124)

  • 41. Prevalence and Progression of Late Gadolinium Enhancement in Children and Adolescents With Hypertrophic Cardiomyopathy.
    Axelsson Raja A; Farhad H; Valente AM; Couce JP; Jefferies JL; Bundgaard H; Zahka K; Lever H; Murphy AM; Ashley E; Day SM; Sherrid MV; Shi L; Bluemke DA; Canter CE; Colan SD; Ho CY
    Circulation; 2018 Aug; 138(8):782-792. PubMed ID: 29622585
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The application of radiology for dilated cardiomyopathy diagnosis, treatment, and prognosis prediction: a bibliometric analysis.
    Fang Q; Huang K; Yao X; Peng Y; Kan A; Song Y; Wang X; Xiao X; Gong L
    Quant Imaging Med Surg; 2023 Oct; 13(10):7012-7028. PubMed ID: 37869323
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Left atrial remodeling in hypertrophic cardiomyopathy and Fabry disease: A CMR-based head-to-head comparison and outcome analysis.
    Moroni A; Tondi L; Milani V; Pieroni M; Pieruzzi F; Bevilacqua F; Pasqualin G; Chow K; Pica S; Lombardi M; Camporeale A
    Int J Cardiol; 2023 Dec; 393():131357. PubMed ID: 37696360
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Complementary Role of Echocardiography and Cardiac Magnetic Resonance in Hypertrophic Cardiomyopathy.
    Hindieh W; Chan R; Rakowski H
    Curr Cardiol Rep; 2017 Sep; 19(9):81. PubMed ID: 28752280
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The emerging role of cardiovascular MRI for risk stratification in hypertrophic cardiomyopathy.
    Hoey ET; Teoh JK; Das I; Ganeshan A; Simpson H; Watkin RW
    Clin Radiol; 2014 Mar; 69(3):221-30. PubMed ID: 24412355
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Bibliometric and Visual Analysis on Metabolomics in Coronary Artery Disease Research.
    Yu N; Wang R; Liu B; Zhang L
    Front Cardiovasc Med; 2022; 9():804463. PubMed ID: 35402548
    [TBL] [Abstract][Full Text] [Related]  

  • 47. NATURAL LANGUAGE PROCESSING BASED MACHINE LEARNING MODEL USING CARDIAC MRI REPORTS TO IDENTIFY HYPERTROPHIC CARDIOMYOPATHY PATIENTS.
    Sundaram DSB; Arunachalam SP; Damani DN; Farahani NZ; Enayati M; Pasupathy KS; Arruda-Olson AM
    Proc Des Med Devices Conf; 2021 Apr; 2021():. PubMed ID: 35463194
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The diagnosis of hypertrophic cardiomyopathy by cardiovascular magnetic resonance.
    Noureldin RA; Liu S; Nacif MS; Judge DP; Halushka MK; Abraham TP; Ho C; Bluemke DA
    J Cardiovasc Magn Reson; 2012 Feb; 14(1):17. PubMed ID: 22348519
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Hypertrophic cardiomyopathy or athlete's heart? A systematic review of novel cardiovascular magnetic resonance imaging parameters.
    Bakogiannis C; Mouselimis D; Tsarouchas A; Papatheodorou E; Vassilikos VP; Androulakis E
    Eur J Sport Sci; 2023 Jan; 23(1):143-154. PubMed ID: 34720041
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Evaluation of Hypertrophic Cardiomyopathy: Newer Echo and MRI Approaches.
    Habib M; Hoss S; Rakowski H
    Curr Cardiol Rep; 2019 Jun; 21(8):75. PubMed ID: 31243594
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Prognostic significance of cardiac magnetic resonance-based markers in patients with hypertrophic cardiomyopathy.
    Dohy Z; Szabo L; Toth A; Czimbalmos C; Horvath R; Horvath V; Suhai FI; Geller L; Merkely B; Vago H
    Int J Cardiovasc Imaging; 2021 Jun; 37(6):2027-2036. PubMed ID: 33555536
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Research Trends in the Application of Artificial Intelligence in Oncology: A Bibliometric and Network Visualization Study.
    Wu T; Duan Y; Zhang T; Tian W; Liu H; Deng Y
    Front Biosci (Landmark Ed); 2022 Aug; 27(9):254. PubMed ID: 36224012
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The diagnostic value of multiparameter cardiovascular magnetic resonance for early detection of light-chain amyloidosis from hypertrophic cardiomyopathy patients.
    Yue X; Yang L; Wang R; Chan Q; Yang Y; Wu X; Ruan X; Zhang Z; Wei Y; Wang F
    Front Cardiovasc Med; 2022; 9():1017097. PubMed ID: 36330005
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The Role of Cardiovascular Magnetic Resonance Imaging in the Evaluation of Hypertrophic Cardiomyopathy.
    Sivalokanathan S
    Diagnostics (Basel); 2022 Jan; 12(2):. PubMed ID: 35204405
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Long term evolution of magnetic resonance imaging characteristics in a case of atypical left lateral wall hypertrophic cardiomyopathy.
    Gassenmaier T; Petritsch B; Kunz AS; Gkaniatsas S; Gaudron PD; Weidemann F; Nordbeck P; Beer M
    World J Cardiol; 2015 Jun; 7(6):357-60. PubMed ID: 26131341
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Diffuse myocardial fibrosis in hypertrophic cardiomyopathy can be identified by cardiovascular magnetic resonance, and is associated with left ventricular diastolic dysfunction.
    Ellims AH; Iles LM; Ling LH; Hare JL; Kaye DM; Taylor AJ
    J Cardiovasc Magn Reson; 2012 Oct; 14(1):76. PubMed ID: 23107451
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Cardiovascular magnetic resonance T2* mapping for the assessment of cardiovascular events in hypertrophic cardiomyopathy.
    Gastl M; Gruner C; Labucay K; Gotschy A; Von Spiczak J; Polacin M; Boenner F; Kelm M; Ruschitzka F; Alkadhi H; Kozerke S; Manka R
    Open Heart; 2020; 7(1):e001152. PubMed ID: 32201584
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Research progress of E-cigarette-A bibliometric analysis during 2010-2022.
    Hong S; Wu F; Yao W; Yang Z; Wei W; Han Z; Feng C; Fan M
    Front Public Health; 2022; 10():928059. PubMed ID: 35979459
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Myocardial fibrosis in hypertrophic cardiomyopathy: accurate reflection of histopathological findings by CMR.
    Moravsky G; Ofek E; Rakowski H; Butany J; Williams L; Ralph-Edwards A; Wintersperger BJ; Crean A
    JACC Cardiovasc Imaging; 2013 May; 6(5):587-96. PubMed ID: 23582356
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Characteristics of the inferior wall hypertrophy in hypertrophic cardiomyopathy patients with contrast echocardiography].
    Liu Z; Zhang W; Jing X; Xiao L; Huang H
    Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2018 Feb; 35(1):92-98. PubMed ID: 29745607
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.